{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:12:45Z","timestamp":1787008365666,"version":"build-2736575974"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study determined the performance characteristics of a quantitative glucose-6-phosphate dehydrogenase (G6PD) assay with automated lysis and evaluated the robustness of the operational workflow following implementation in a hospital laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The G6PD activity was measured in whole blood using an enzymatic quantitative test on a Roche cobas c501 analyzer with onboard lysis configuration and normalized to hemoglobin (Hb). The performance characteristics of the method and stability of G6PD in whole blood collected in EDTA-containing tubes were evaluated, and the reference interval was established on a population of healthy individuals (n = 279). The robustness of this automated workflow for sample lysis was evaluated during validation and after implementation for routine clinical use for 18 months and in 2,181 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The G6PD assay was linear from 0.7 to 16.5 U\/g Hb. Inter- and intra-assay precision using control and patient samples was below 12%. The G6PD results correlated well with a reference laboratory method (r = 0.96, y = 0.9615x \u2013 1.222). The reference interval in our population was 9.8 to 15.5 U\/g Hb. There were no interferences by lipemia and icteria, although grossly hemolyzed specimens may be affected. The testing workflow requires analyzing samples within minutes from mixing and loading into the instrument to avoid sample sedimentation. Measures to repeat samples with Hb 8.0 g\/dL or less identified sedimented samples. In our patient population, 10.6% and 5.8% of the total males and females tested were G6PD deficient, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The G6PD assay with automated lysis is acceptable for patient testing. Several measures ensured the robustness of this workflow in a hospital laboratory.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqae106","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T11:17:08Z","timestamp":1721215028000},"page":"153-160","source":"Crossref","is-referenced-by-count":4,"title":["Analytical and operational considerations of measuring glucose 6-phosphate dehydrogenase (G6PD) activity using a fully automated assay"],"prefix":"10.1093","volume":"163","author":[{"given":"Sarah","family":"Zilka","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhan","family":"Wei","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Payto","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Doyle","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah Health , Salt Lake City, UT ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-205X","authenticated-orcid":false,"given":"Jennifer","family":"Hockings","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Center for Personalized Genetic Healthcare, Cleveland Clinic Foundation , Cleveland, OH ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M","family":"Col\u00f3n-Franco","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, Cleveland Clinic Foundation , Cleveland, OH ,","place":["US"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"issue":"12","key":"2025012906105866800_CIT0001","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/ijms17122069","article-title":"Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world","volume":"17","author":"G\u00f3mez-Manzo","year":"2016","journal-title":"Int J Mol Sci ."},{"key":"2025012906105866800_CIT0002","article-title":"Technical consultation to review the classification of glucose-6-phosphate dehydrogenase (G6PD)","author":"World Health Organization","year":"2022","journal-title":"Malar Policy Advis Group Meet."},{"issue":"7","key":"2025012906105866800_CIT0003","first-page":"1277","article-title":"Diagnosis and management of G6PD deficiency","volume":"72","author":"Frank","year":"2005","journal-title":"Am Fam Physician."},{"key":"2025012906105866800_CIT0004","article-title":"Glucose-6-Phosphate Dehydrogenase Deficiency","author":"Richardson","year":"2023"},{"issue":"5","key":"2025012906105866800_CIT0005","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/cpt.2735","article-title":"Expanded clinical pharmacogenetics implementation consortium guideline for medication use in the context of G6PD genotype","volume":"113","author":"Gammal","year":"2023","journal-title":"Clin Pharmacol Ther."},{"issue":"24","key":"2025012906105866800_CIT0006","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.1073\/pnas.81.24.7855","article-title":"Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site","volume":"81","author":"Szabo","year":"1984","journal-title":"Proc Natl Acad Sci USA."},{"issue":"4","key":"2025012906105866800_CIT0007","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/vox.12068","article-title":"Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks","volume":"105","author":"Francis","year":"2013","journal-title":"Vox Sang."},{"issue":"3","key":"2025012906105866800_CIT0008","doi-asserted-by":"publisher","first-page":"101610","DOI":"10.1016\/j.jbc.2022.101610","article-title":"Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants","volume":"298","author":"Garcia","year":"2022","journal-title":"J Biol Chem."},{"issue":"11","key":"2025012906105866800_CIT0009","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.celrep.2017.02.048","article-title":"Coupling between protein stability and catalytic activity determines pathogenicity of G6PD variants","volume":"18","author":"Cunningham","year":"2017","journal-title":"Cell Rep"},{"issue":"1","key":"2025012906105866800_CIT0010","doi-asserted-by":"publisher","first-page":"24307","DOI":"10.1038\/s41598-021-03800-z","article-title":"Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency","volume":"11","author":"Pakparnich","year":"2021","journal-title":"Sci Rep."},{"issue":"2","key":"2025012906105866800_CIT0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/jp.2010.69","article-title":"Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States","volume":"31","author":"Nock","year":"2010","journal-title":"J Perinatol."},{"issue":"6","key":"2025012906105866800_CIT0012","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0009922814557786","article-title":"Pediatric provider insight into newborn screening for G6PD deficiency","volume":"54","author":"Bernardo","year":"2015","journal-title":"Clin Pediatr (Phila)."},{"issue":"3","key":"2025012906105866800_CIT0013","doi-asserted-by":"publisher","first-page":"e2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics."},{"key":"2025012906105866800_CIT0014","doi-asserted-by":"publisher","first-page":"45963","DOI":"10.1038\/srep45963","article-title":"Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis","volume":"7","author":"Mbanefo","year":"2017","journal-title":"Sci Rep."},{"key":"2025012906105866800_CIT0015","article-title":"Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women","author":"Peters","year":"2024"},{"issue":"5","key":"2025012906105866800_CIT0016","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/pathogens12050650","article-title":"A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria","volume":"12","author":"Sadhewa","year":"2023","journal-title":"Pathogens"},{"issue":"5","key":"2025012906105866800_CIT0017","doi-asserted-by":"publisher","first-page":"119","DOI":"10.11648\/j.cmr.20180705.13","article-title":"Modification of the Pointe Scientific Automated Glucose-6-Phosphate Dehydrogenase (G6PD) Assay for high-throughput use in the clinical laboratory","volume":"7","author":"Milner","year":"2018","journal-title":"Clin Med Res"},{"issue":"1","key":"2025012906105866800_CIT0018","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s13104-018-3964-7","article-title":"Spectrophotometry assays to determine G6PD activity from trinity biotech and pointe scientific G6PD show good correlation","volume":"11","author":"Alam","year":"2018","journal-title":"BMC Res Notes."},{"issue":"5","key":"2025012906105866800_CIT0019","doi-asserted-by":"publisher","first-page":"e1003084","DOI":"10.1371\/journal.pmed.1003084","article-title":"Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: a systematic review and meta-analysis","volume":"17","author":"Pfeffer","year":"2020","journal-title":"PLoS Med."},{"issue":"2","key":"2025012906105866800_CIT0020","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ajcp\/aqaa040","article-title":"Evaluating percentage-based reporting of glucose-6-phosphate dehydrogenase (G6PD) enzymatic activity: assessment of patient eligibility for malaria prevention and treatment with Tafenoquine","volume":"154","author":"Calvaresi","year":"2020","journal-title":"Am J Clin Pathol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/1\/153\/58843888\/aqae106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/1\/153\/58843888\/aqae106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:11:04Z","timestamp":1738113064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/163\/1\/153\/7735303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,17]]},"published-print":{"date-parts":[[2025,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqae106","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,8,17]]}}}